The Sage Group plc (LON:SGE)
London · Delayed Price · Currency is GBP · Price in GBp | Market Cap | 10.20B |
| Revenue (ttm) | 2.51B |
| Net Income (ttm) | 369.00M |
| Shares Out | 948.16M |
| EPS (ttm) | 0.37 |
| PE Ratio | 28.96 |
| Forward PE | 21.43 |
| Dividend | 0.21 (1.95%) |
| Ex-Dividend Date | May 29, 2025 |
| Volume | 10,022,797 |
| Average Volume | 2,579,409 |
| Open | 1,157.00 |
| Previous Close | 1,076.00 |
| Day's Range | 1,077.50 - 1,157.00 |
| 52-Week Range | 1,034.50 - 1,349.00 |
| Beta | 0.45 |
| RSI | 48.07 |
| Earnings Date | Nov 19, 2025 |
About The Sage Group
The Sage Group plc, together with its subsidiaries, provides technology solutions and services for small and medium businesses in North America, Europe, the United Kingdom, Ireland, Africa and Asia-Pacific. It offers Sage Intacct, cloud accounting and financial management software for mid-sized and growing businesses; Sage People, an integrated HR and Payroll solution; Sage 200, a scalable management solution; Sage X3, a flexible, intuitive, and tailored business solution; Sage Accounting, a cloud software for managing invoicing, cash flow, tax... [Read more]
Financial Performance
In 2025, The Sage Group's revenue was 2.51 billion, an increase of 7.76% compared to the previous year's 2.33 billion. Earnings were 369.00 million, an increase of 14.24%.
Financial StatementsNews
Sage Group (SGGEF) Reports Strong FY Results with Revenue Growth and Dividend Increase
Sage Group (SGGEF) Reports Strong FY Results with Revenue Growth and Dividend Increase
Sage Group Launches $394 Million Buyback After Profit, Revenue Rise
Sage Non-GAAP EPS of 43.20p, revenue of £2.51B; announces £300m share buyback program, gives FY outlook
Sage Group press release (SGGEF): FY Non-GAAP EPS of 43.20p. Revenue of £2.51B (+7.7% Y/Y). Underlying total revenue increased by 10% to £2,513m,
Sage Group FY25 Results Rise, Sees Growth In FY26, Ahead; Lifts Dividend, Plans GBP 300 Mln Buyback
(RTTNews) - Sage Group plc (SGE.L), a British enterprise software company, reported Wednesday higher profit and revenues in fiscal 2025.
Sage Group (SGPYY) Upgraded to Strong Buy: Here's What You Should Know
Sage Group (SGPYY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Sage’s AI-Powered Accounting Suite Launch Sparks FTSE 100 Rally, Shares Climb 3% on Citi Upgrade
London, October 13, 2025 – Sage Group plc, an accounting software industry leader based in Newcastle-upon-Tyne, launched its latest generation AI-enabled platform today, sending a tsunami of its stock...
The Sage Group plc (SGGEF) Presents at Sales/Trading Statement Conference Transcript
The Sage Group plc (OTCPK:SGGEF) Sales/Trading Statement Conference Call July 30, 2025 3:30 AM ET Company Participants Jonathan Anton George Howell - CFO & Director Conference Call Participants Adam D...
According to THE SAGE GROUP, The Current United States Prevalence of Chronic Venous Disease (CVD) Exceeds 190 Million. The Most Severe Stage, Chronic Venous Insufficiency (CVI), Afflicts Over 50 Million.
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CVD--A new report published by THE SAGE GROUP quantifies CVD prevalence and incidence for the 2020-2040 period. “Chronic venous disease afflicts 1.5 times as many pe...
The Sage Group plc (SGGEF) Q2 2025 Earnings Call Transcript
Sage Group reports 1H results
UK's Sage Group says Cartin to replace Howell as CFO next year
British software firm Sage Group named Jacqui Cartin as its new chief financial officer on Thursday, succeeding Jonathan Howell, who will leave on December 31.
The Sage Group Is Growing Well, But It Is Still Too Expensive
The Sage Group plc (SGGEF) Q1 2025 Earnings Call Transcript
FTSE-100 software group Sage braced for row over recruitment awards
Sage Group, the FTSE-100 software provider, is braced for an investor backlash after proposing big increases to new executives' potential pay packages.
According to THE SAGE GROUP, Over 3.5 Million Critical Limb Ischemia (CLI) Patients Have Calcified Lower Limb Arteries
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CLIFighters--A new report published by THE SAGE GROUP reviews recent calcium research and quantifies the number of CLI patients with calcified leg arteries. “Almost ...
The Sage Group plc (SGGEF) Q4 2024 Earnings Call Transcript
The Sage Group plc (OTCPK:SGGEF) Q4 2024 Earnings Conference Call November 20, 2024 3:30 AM ETCompany ParticipantsSteve Hare - Chief executive...
The Sage Group plc 2024 Q4 - Results - Earnings Call Presentation
Sage Shares Hit Record After Announcing £400 Million Buyback
Sage Group Plc jumped to a record high after the UK software company announced a share buyback plan of as much as £400 million ($508 million) reflecting what it called a strong financial position.
UK software firm Sage Group reports 21% rise in profit
Britain's Sage Group reported a better-than-expected 21% rise in full-year operating profit to 529 million pounds ($672 million) driven by a 220 basis points margin increase, and said it expected cont...
The Sage Group Has A Good Product, But The Stock Is Too Expensive
According to THE SAGE GROUP, The Majority of Endovascular Revascularizations Performed for Peripheral Artery Disease (PAD) are Outpatient
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CLTI--Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing endovascular procedures by site of service; hospital inpatient, hosp...
According to THE SAGE GROUP, Less Than 20% of Symptomatic Peripheral Artery Disease (PAD) Patients Are Revascularized
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CLIFighters--Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing surgical bypass and endovascular revascularization in the U.S...
According to THE SAGE GROUP, There is a Significant Need for Innovative Endovascular Devices to Treat Below-the-Ankle (BTA) Disease in Critical Limb Ischemia (CLI) Patients
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CLIFighters--Research published by THE SAGE GROUP examines the prevalence, characteristics, comorbidities and consequences of BTA disease, as well as explores the ch...